1. The cancer multiple myeloma, which damages plasma cells in the bone marrow, is treated with bortezomib as a component of combination therapy.
2. Mantle Cell Lymphoma: This non-Hodgkin's lymphoma variant, which develops from B-cells, is also treated with it.
The most common way to administer bortezomib is through an intravenous (IV) injection, which delivers the drug directly into the bloodstream through a vein. Depending on the type and stage of the cancer as well as the unique characteristics of the patient, the dosage and treatment plan may change.
Bortezomib may induce negative effects, as is the case with most drugs. Low blood cell counts, exhaustion, nausea, vomiting, diarrhoea, and peripheral neuropathy (tingling or numbness in the hands and feet) are a few of the most typical adverse effects. During or soon after the medicine delivery, some individuals may also have infusion-related effects.
While taking Bortezomib medication, patients must be continuously watched by their healthcare team in order to manage and treat any potential adverse effects.
If "Bortecad" (Bortezomib Injection 2mg) is a prescribed medication or a product with a different name, I suggest speaking with a knowledgeable healthcare professional, going to a trustworthy medical resource, or getting in touch with the pharmaceutical company directly for information about the medication, its uses, dosage, potential side effects, and the right way to administer it.
MEHADIA TRADELINKS
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |